Evaluation of Treatment Strategies and Survival of Patients with cT4bM0 Esophageal Cancer: A Nationwide Cohort Study
Digestive Surgery · 2024
DOI: 10.1159/000540214 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Digestive Surgery, 2024. Verfasst von Jingpu Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands, wang_jingpu@hotmail.com. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoplasm Staging, Esophagectomy, Chemoradiotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Introduction
The optimal therapeutic strategy for patients with cT4bM0 esophageal cancer is controversial and varies internationally. This study aimed to describe treatment and survival of patients with cT4bM0 esophageal cancer in the Netherlands.
Methods
Patients staged with cT4bM0 esophageal cancer who were registered in the Netherlands Cancer Registry (NCR) were included. All patients were categorized by the treatment modality received. The Kaplan-Meier method was used to estimate the overall survival of them.
Results
Between 2015 and 2020, 286 patients with cT4bM0 esophageal cancer were included. Treatment consisted of preoperative chemoradiotherapy/chemotherapy followed by surgery (8%), chemoradiotherapy alone (35%), chemotherapy alone (6%), radiotherapy alone (19%), and best supportive care (32%). The median follow-up was 28.1 months. The 1-, 3-, and 5-year survival rates of each group were 82%, 58%, 49% for preoperative therapy plus surgery; 53%, 27%, 16% for chemoradiotherapy only; 13%, 0%, 0% for chemotherapy only; 13%, 0%, 0% for radiotherapy only; and 5%, 0%, 0% for best supportive care.
Conclusion
In a selected group of patients, preoperative therapy followed by esophagectomy may lead to improved survival, which is comparable to patients with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands, wang_jingpu@hotmail.com.
- Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Surgery, Peking University Cancer Hospital and Institute, Beijing, China.
- Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research & Development, Utrecht, The Netherlands.
- Amsterdam UMC Location University of Amsterdam, Medical Oncology, Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.
Zitieren
APA
Wang, J., de Groot, E. M., Wu, Z., Verhoeven, R. H. A., Haj Mohammad, N., Mook, S., Goense, L., Markar, S. R., Ruurda, J. P., & van Hillegersberg, R. (2024). Evaluation of Treatment Strategies and Survival of Patients with cT4bM0 Esophageal Cancer: A Nationwide Cohort Study. Digestive Surgery. https://doi.org/10.1159/000540214
Vancouver
Wang J, de Groot EM, Wu Z, Verhoeven RHA, Haj Mohammad N, Mook S, et al. Evaluation of Treatment Strategies and Survival of Patients with cT4bM0 Esophageal Cancer: A Nationwide Cohort Study. Digestive Surgery. 2024. doi:10.1159/000540214
BibTeX
@article{Wang2024,
author = {Wang, Jingpu and de Groot, Eline M and Wu, Zhouqiao and Verhoeven, Rob H A and Haj Mohammad, Nadia and Mook, Stella and Goense, Lucas and Markar, Sheraz R and Ruurda, Jelle P and van Hillegersberg, Richard},
title = {Evaluation of Treatment Strategies and Survival of Patients with cT4bM0 Esophageal Cancer: A Nationwide Cohort Study},
journal = {Digestive Surgery},
year = {2024},
doi = {10.1159/000540214}
}
EUVIMED